CD274 and cancer: In the cancer setting, the ligands for PD-1, PD-L1 (thought to be the predominant ligand) and PD-L2, are expressed in the tumor microenvironment (Pardoll, 2012; Nirschl & Drake, 2013; Zou & Chen, 2008).